BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $297,660 | -26.4% | 5,856 | -5.6% | 0.00% | – |
| Q2 2023 | $404,246 | -41.3% | 6,202 | -59.6% | 0.00% | -100.0% |
| Q1 2023 | $688,536 | -31.2% | 15,340 | -34.3% | 0.00% | 0.0% |
| Q4 2022 | $1,001,400 | -21.9% | 23,359 | +22.4% | 0.00% | -50.0% |
| Q3 2022 | $1,283,000 | -35.5% | 19,090 | -50.5% | 0.00% | -33.3% |
| Q2 2022 | $1,990,000 | +20.2% | 38,553 | +50.1% | 0.00% | +50.0% |
| Q1 2022 | $1,656,000 | +333.5% | 25,681 | +593.9% | 0.00% | – |
| Q3 2021 | $382,000 | -29.8% | 3,701 | -40.1% | 0.00% | -100.0% |
| Q2 2021 | $544,000 | +28.9% | 6,179 | +41.3% | 0.00% | – |
| Q1 2021 | $422,000 | -50.6% | 4,372 | -42.6% | 0.00% | -100.0% |
| Q4 2020 | $854,000 | +258.8% | 7,620 | +202.3% | 0.00% | – |
| Q2 2019 | $238,000 | +7.2% | 2,521 | -9.2% | 0.00% | – |
| Q1 2019 | $222,000 | – | 2,775 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |